Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients.

[1]  D. Evans,et al.  The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis , 2019, Genetics in Medicine.

[2]  K. Stefánsson,et al.  Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome , 2019, Journal of Medical Genetics.

[3]  P. Goodfellow,et al.  Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer , 2018, JAMA oncology.

[4]  Wei Chen,et al.  Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival. , 2017, Gynecologic oncology.

[5]  P. Goodfellow,et al.  Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer , 2017, JAMA oncology.

[6]  Sheena M. Scroggins,et al.  Improving performance of multigene panels for genomic analysis of cancer predisposition , 2016, Genetics in Medicine.

[7]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[8]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[9]  E. Kuipers,et al.  Somatic aberrations of mismatch repair genes as a cause of microsatellite‐unstable cancers , 2014, The Journal of pathology.

[10]  W. Frankel,et al.  Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. , 2014, Gastroenterology.

[11]  Practice Bulletin No. 147: Lynch Syndrome , 2014, Obstetrics and gynecology.

[12]  D. Evans,et al.  Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC) , 2014, Journal of Medical Genetics.

[13]  I. Nagtegaal,et al.  Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. , 2014, Gastroenterology.

[14]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[15]  J. Potter,et al.  Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.

[16]  Jeffrey R. Botkin,et al.  Summary of Recommendations: The Evaluation of Genomic Applications , 2022 .

[17]  J. Mecklin,et al.  The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome , 2008, International journal of cancer.

[18]  W. Frankel,et al.  Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients. , 2007, Cancer research.

[19]  W. Frankel,et al.  Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.

[20]  W. Frankel,et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.

[21]  H. Lynch,et al.  Cancer risk in mismatch repair gene mutation carriers , 2004, Familial Cancer.

[22]  L. Aaltonen,et al.  Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.